Telos Capital Management Inc. Purchases 1,710 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Telos Capital Management Inc. grew its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 27,816 shares of the exchange traded fund’s stock after purchasing an additional 1,710 shares during the quarter. Telos Capital Management Inc.’s holdings in SPDR S&P Biotech ETF were worth $2,505,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Truist Financial Corp increased its stake in shares of SPDR S&P Biotech ETF by 0.8% in the 2nd quarter. Truist Financial Corp now owns 32,773 shares of the exchange traded fund’s stock valued at $3,038,000 after acquiring an additional 252 shares in the last quarter. Sanctuary Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at $1,247,000. GAMMA Investing LLC increased its stake in shares of SPDR S&P Biotech ETF by 7,173.3% in the 3rd quarter. GAMMA Investing LLC now owns 1,091 shares of the exchange traded fund’s stock valued at $108,000 after acquiring an additional 1,076 shares in the last quarter. Dynamic Advisor Solutions LLC increased its stake in shares of SPDR S&P Biotech ETF by 1.4% in the 3rd quarter. Dynamic Advisor Solutions LLC now owns 15,276 shares of the exchange traded fund’s stock valued at $1,509,000 after acquiring an additional 209 shares in the last quarter. Finally, Daymark Wealth Partners LLC increased its stake in shares of SPDR S&P Biotech ETF by 0.9% in the 3rd quarter. Daymark Wealth Partners LLC now owns 17,750 shares of the exchange traded fund’s stock valued at $1,754,000 after acquiring an additional 150 shares in the last quarter.

SPDR S&P Biotech ETF Stock Down 1.4 %

NYSEARCA:XBI opened at $93.37 on Friday. The company has a fifty day moving average of $92.75 and a 200-day moving average of $96.55. The firm has a market capitalization of $7.12 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.